FI119640B - Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia - Google Patents

Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia Download PDF

Info

Publication number
FI119640B
FI119640B FI971274A FI971274A FI119640B FI 119640 B FI119640 B FI 119640B FI 971274 A FI971274 A FI 971274A FI 971274 A FI971274 A FI 971274A FI 119640 B FI119640 B FI 119640B
Authority
FI
Finland
Prior art keywords
alkyl
formula
chloro
dihydro
amino
Prior art date
Application number
FI971274A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971274A0 (fi
FI971274A (fi
Inventor
Daele Georges Henri Paul Van
Den Keybus Frans Maria Alf Van
Jean-Paul Rene Marie A Bosmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI971274A0 publication Critical patent/FI971274A0/fi
Publication of FI971274A publication Critical patent/FI971274A/fi
Application granted granted Critical
Publication of FI119640B publication Critical patent/FI119640B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI971274A 1994-09-27 1997-03-26 Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia FI119640B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
US45548695 1995-05-31
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives
EP9503691 1995-09-19

Publications (3)

Publication Number Publication Date
FI971274A0 FI971274A0 (fi) 1997-03-26
FI971274A FI971274A (fi) 1997-03-26
FI119640B true FI119640B (fi) 2009-01-30

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971274A FI119640B (fi) 1994-09-27 1997-03-26 Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia

Country Status (23)

Country Link
EP (1) EP0784620B1 (zh)
JP (1) JP3953097B2 (zh)
CN (1) CN1068880C (zh)
AT (1) ATE187453T1 (zh)
AU (1) AU699152B2 (zh)
BR (1) BR9509036A (zh)
CA (1) CA2200578C (zh)
CZ (1) CZ289031B6 (zh)
DE (1) DE69513846T2 (zh)
DK (1) DK0784620T3 (zh)
ES (1) ES2141383T3 (zh)
FI (1) FI119640B (zh)
GR (1) GR3032646T3 (zh)
HU (1) HU218698B (zh)
IL (1) IL115413A (zh)
MY (1) MY113202A (zh)
NO (1) NO313238B1 (zh)
NZ (1) NZ293605A (zh)
PL (1) PL182502B1 (zh)
PT (1) PT784620E (zh)
RU (1) RU2154064C2 (zh)
WO (1) WO1996010027A1 (zh)
ZA (1) ZA958081B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753706B2 (en) * 1998-05-14 2002-10-24 Egis Gyogyszergyar Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
KR101023433B1 (ko) * 2002-01-16 2011-03-25 얀센 파마슈티카 엔.브이. 프루칼로프리드-ｎ-옥사이드
ES2340855T3 (es) 2003-12-23 2010-06-10 Serodus As Modulares de receptores 5-ht perifericos.
NZ551603A (en) 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
EP1945632B1 (en) 2005-11-08 2013-09-18 Vertex Pharmaceuticals Incorporated Heterocyclic modulators of atp-binding cassette transporters
NZ581259A (en) 2007-05-09 2012-07-27 Vertex Pharma Modulators of cystic fibrosis transmembrane conductance regulator
DK2639224T3 (en) 2007-12-07 2016-10-17 Vertex Pharma A process for the preparation of cycloalkylcarboxiamido-pyridinbenzoesyrer
NZ702159A (en) 2007-12-07 2016-03-31 Vertex Pharma Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
NZ720282A (en) 2008-02-28 2017-12-22 Vertex Pharma Heteroaryl derivatives as cftr modulators
EP3150198B1 (en) 2010-04-07 2021-09-22 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
SI2555754T1 (sl) * 2010-04-07 2016-07-29 Vertex Pharmaceuticals Incorporated Trdne farmacevtske oblike 3-(6-(1-(2,2-difluoro-benzo(d)(1,3)dioksol-5- il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojske kisline
KR102280372B1 (ko) 2013-11-12 2021-07-22 버텍스 파마슈티칼스 인코포레이티드 Cftr 매개된 질환 치료용 약제학적 조성물의 제조 방법
HUE055423T2 (hu) 2014-11-18 2021-11-29 Vertex Pharma Eljárás nagy áteresztõképességû tesztelõ nagy teljesítményû folyadék-kromatográfia elvégzésére

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
CA2116024A1 (en) * 1991-08-20 1993-03-04 Francis David King 5-ht4 receptor antagonists
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
CZ289031B6 (cs) 2001-10-17
NZ293605A (en) 1998-07-28
ES2141383T3 (es) 2000-03-16
RU2154064C2 (ru) 2000-08-10
MX9702363A (es) 1997-10-31
EP0784620B1 (en) 1999-12-08
AU699152B2 (en) 1998-11-26
JP3953097B2 (ja) 2007-08-01
CA2200578A1 (en) 1996-04-04
ZA958081B (en) 1997-03-26
JPH10506118A (ja) 1998-06-16
IL115413A (en) 2000-02-17
PT784620E (pt) 2000-05-31
FI971274A0 (fi) 1997-03-26
CN1068880C (zh) 2001-07-25
MY113202A (en) 2001-12-31
CN1166171A (zh) 1997-11-26
NO971376L (no) 1997-05-05
NO313238B1 (no) 2002-09-02
CZ91897A3 (en) 1997-12-17
PL182502B1 (pl) 2002-01-31
ATE187453T1 (de) 1999-12-15
PL319997A1 (en) 1997-09-01
WO1996010027A1 (en) 1996-04-04
EP0784620A1 (en) 1997-07-23
NO971376D0 (no) 1997-03-24
HUT77173A (hu) 1998-03-02
GR3032646T3 (en) 2000-06-30
BR9509036A (pt) 1997-10-14
CA2200578C (en) 2006-11-07
AU3608195A (en) 1996-04-19
HU218698B (hu) 2000-11-28
FI971274A (fi) 1997-03-26
DK0784620T3 (da) 2000-05-22
DE69513846T2 (de) 2000-07-06
IL115413A0 (en) 1995-12-31
DE69513846D1 (de) 2000-01-13

Similar Documents

Publication Publication Date Title
FI101624B (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyy li)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentso dioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
KR100500372B1 (ko) 위장운동 조절성 3- 또는 4-치환된4-(아미노메틸)-피페리딘 유도체의 비사이클릭 벤즈아미드
FI119640B (fi) Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia
SK282406B6 (sk) N-(4-Piperidinyl) (dihydrobenzofurán alebo dihydro-2H-benzopyrán) karboxamidové deriváty, spôsob a medziprodukty na ich výrobu a farmaceutické prípravky na ich báze
FI94129B (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
US6544997B1 (en) 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
US5053411A (en) N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
AU718695B2 (en) Esters of 3-hydroxy-piperidinemethanol derivatives
WO2005030722A1 (ja) Ｎ－置換－ｎ－（４－ピペリジニル）アミド誘導体
USRE34201E (en) N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds
JP3862750B2 (ja) フェニル−オキソ−アルキル−（４−ピペリジニル）ベンゾエート誘導体
MXPA97002363A (es) Derivados biciclicos de benzoato de piperidinilon-substituidos
MXPA01006409A (en) 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
MXPA97002356A (en) Derivatives of phenyl-oxy-alkyl- (4-piperidinyl) benzo
PL182174B1 (pl) srodek farmaceutyczny i sposób wytwarzania pochodnychbenzoesanu fenylo-okso-alkilo-(4-piperydynylu) PL PL